3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
25
Stage II Prostate Adenocarcinoma
1
Salivary Gland Neoplasms
1
Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Interventions
enzalutamide
1
apalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Metastatic Hormone-sensitive Prostate Cancer
×
apalutamide
×
Clear all
NCT05901649
2026-06-05
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
504 enrolled